JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FURNER, R. L.
Right arrow Articles by ANDERS, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FURNER, R. L.
Right arrow Articles by ANDERS, M. W.
Journal of Pharmacology And Experimental Therapeutics, Vol. 169, Issue 2, 153-158, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


STEREOSELECTIVE METABOLISM OF THE ENANTIOMERS OF HEXOBARBITAL

R. L. FURNER 1, J. S. McCARTHY 1, R. E. STITZEL 1, and M. W. ANDERS 1

1 Department of Pharmacology, West Virginia University Medical Center, Morgantown, West Virginia and Department of Physiology, New York State Veterinary College, Cornell University, Ithaca, New York

Stereoselectivity in the microsomal metabolism of hexobarbital has been investigated. In both male and female rats l-hexobarbital has a longer latency, has a longer half-life and achieves higher blood levels after equivalent doses of the two enantiomers. The l-enantiomer is a more potent anesthetic in females but produces approximately equal sleeping times in male rats. The reason for the similar biologic potency in males despite a faster rate of metabolism of the d-enantiomer is not clear. Studies of microsomal metabolism indicate that male rats metabolize d-hexobarbital faster than the l-enantiomer and that males metabolize both optically active forms faster than females. Pretreatment with phenobarbital, but not 3-methylcholanthrene, always resulted in increased rates of metabolism for both enantiomers. Experiments with SKF 525A as an inhibitor of microsomal metabolism point out the need to consider the role of stereochemistry in inhibition studies.

Submitted on November 8, 1968
Accepted on June 19, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.